Increased EphA4-ephexin1 signaling in the medial prefrontal cortex plays a role in depression-like phenotype-Reference-Cited by-同舟云学术

Increased EphA4-ephexin1 signaling in the medial prefrontal cortex plays a role in depression-like phenotype

Published:2017-08-02 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Zhang Ji-chun,Yao Wei,Qu Youge,Nakamura Mayumi,Dong Chao,Yang Chun,Ren Qian^ORCID,Ma Min,Han Mei,Shirayama Yukihiko,Hayashi-Takagi Akiko,Hashimoto Kenji

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-07325-2.pdf

Reference66 articles.

1. World Health Organization (WHO). Depression Fact sheet No. 369/October 2012; Available at http://www.who.int/mediacentre/factsheets/fs369/en/index.html .

2. Whooley, M. A. & Simon, G. E. Managing depression in medical outpatients. N Eng J Med 343, 1942–1950 (2000).

3. Rush, A. J. et al. Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry 168, 689–701 (2011).

4. Guidi, J., Tomba, E. & Fava, G. A. The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: A meta-analysis of the sequential model and a critical review of the literature. Am J Psychiatry 173, 128–137 (2016).

5. Hashimoto, K. Inflammatory biomarkers as differential predictors of antidepressant response. Int J Mol Sci 16, 7796–7801 (2015).

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EphA4 Induces the Phosphorylation of an Intracellular Adaptor Protein Dab1 <i>via</i> Src Family Kinases;Biological and Pharmaceutical Bulletin;2024-07-18

2. Advanced researches of traditional uses, phytochemistry, pharmacology, and toxicology of medical Uncariae Ramulus Cum Uncis;Journal of Ethnopharmacology;2024-05

3. Electroacupuncture ameliorates chronic unpredictable mild stress-induced depression-like behavior and cognitive impairment through suppressing oxidative stress and neuroinflammation in rats;Brain Research Bulletin;2024-01

4. Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential;Aging and disease;2024

5. Lipidation and PEGylation strategies to prolong the in vivo half-life of a nanomolar EphA4 receptor antagonist;European Journal of Medicinal Chemistry;2023-12